ENVB
Enveric Biosciences·NASDAQ
--
--(--)
--
--(--)
ENVB fundamentals
Enveric Biosciences (ENVB) released its earnings on Nov 14, 2025: revenue was -- (YoY --), beat estimates; EPS was -10.81 (YoY +74.98%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-10.81
+74.98%
Report date
Nov 14, 2025
EPS
Actual | -2790 | -790.2 | -561.6 | -415.8 | -234 | -262.8 | -109.8 | -41.4 | -43.2 | -57.96 | -14.64 | -11.64 | -10.81 | ||||||||||
Forecast | -1440 | -675 | -630 | -401.4 | -376.2 | -284.4 | -139.5 | -99 | -93.6 | -41.4 | -72 | -63 | -63 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -93.75% | -17.07% | +10.86% | -3.59% | +37.80% | +7.59% | +21.29% | +58.18% | +53.85% | -40.00% | +79.67% | +81.52% | +82.84% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | -- | 0 | -- | -- | -- |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Enveric Biosciences next quarter?What were the key takeaways from Enveric Biosciences's earnings call?What were the key takeaways from Enveric Biosciences’s earnings call?What is Enveric Biosciences's gross profit margin?What guidance did Enveric Biosciences's management provide for the next earnings period?What is the revenue and EPS growth rate for Enveric Biosciences year over year?What does Enveric Biosciences do and what are its main business segments?What factors drove the changes in Enveric Biosciences's revenue and profit?
